Newsfeeds - Spark Newswire

1 minute read

MeiraGTx’s Investigational Candidate Shows Improvement In Radiation Induced Dry Mouth Symptoms

Today, 10:16 AM

MeiraGTx Holdings plc (NASDAQ:MGTX) announced positive clinical data from the ongoing Phase 1 AQUAx study of AAV2-hAQP1 for grade 2/3 radiation-induced…

MGTX

7 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 10:16 AM

During Thursday's session, 97 companies made new 52-week lows.

ACST

1 minute read

MeiraGTx Holdings Q2 EPS $0.76 Up From $(0.46) YoY

By Benzinga Newsdesk

Today, 10:16 AM

MeiraGTx Holdings (NASDAQ:MGTX) reported quarterly earnings of $0.76 per share. This is a 265.22 percent increase over losses of $(0.46) per share from the same period last year.

MGTX

8 minute read

This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:16 AM

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.

AAWW

5 minute read

Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 10:16 AM

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.

AAWW

1 minute read

MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial

By Vandana Singh

Today, 10:16 AM

MeiraGTx Holdings plc (NASDAQ:MGTX) announced topline data from the Phase 1/2 study MGT009 of botaretigene sparoparvovec, gene therapy for X-linked retinitis…

JNJ